049sek
0,0 %
Date:2024-04-23Time:11:25:15Latest report:Q4-2023List:Small CapTicker:IMMU
Market Cap:494 msekEnterprise Value:396 msekNet Sales:- msekEarnings:-101,6 msekEmployees:0ISIN:SE0005003654

Ratios

10-year key figure history for Mendus turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Mendus with index and moving average MA50 and MA200.

Stockprice:0,49
MA50:0,48
MA200:0,46
Price/MA200:5,7 %
RSI (14):52,2
Price/MA50:2,1 %

Description

Mendus AB is a clinical-level biopharmaceutical company that focuses on the development of immunotherapies that address tumor recurrence and difficult-to-treat established tumors. Its operations consist of research and development for pharmaceuticals.

Biotechnology